LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing Articles
The FTSE 100 is near its lowest in a year! I’d buy these shares now

Investing Articles
Best British shares to buy in September
Investing Articles
FTSE 100 reshuffle: 2 shares I’d buy in September

Investing Articles
What are the top FTSE 100 dividend shares to buy now?

Page
Investing in Healthcare: Top UK Healthcare Stocks in 2022

Investing Articles
I think these are the best shares to buy now for the next decade

Investing Articles
Down 30%, here’s a dirt-cheap FTSE 100 stock to buy on the dip

Investing Articles
I reckon these 2 FTSE 100 stocks are among the best shares to buy now

Investing Articles
These FTSE 100 stocks are big fallers. I think they’re too cheap
Investing Articles
Top British growth stocks to buy in June
Investing Articles
3 cheap FTSE 100 dividend shares I’d buy now and hold until 2032
